LJN Newsletters

Discussion of a case in which a Berkeley Law Dean was sued for sexual harassment.

Security issues are cited repeatedly as the number one concern for law firms and most recently topped all other current trends. This year, firms are estimated to spend more than $6.9 million or 1.92% of their gross annual revenues on information security.

Who's doing what; who's going where.

Landlord shall assure Tenant of quiet enjoyment and possession of the Premises, and Tenant shall enjoy all rights herein granted without interference." This type of clause, in one form or another, is likely to be found in any commercial lease. This article discusses some considerations for drafting this covenant, including ways by which a landlord may limit its scope.

How courts are determining the parameters of an enforceable right of publicity is a highly active area of entertainment law. There should be a uniform set of defenses to a right of publicity claim. But under existing case law, the right of publicity is schizophrenic; some courts let the cause of action overflow its intended banks, swamping all that lies before it, including the First Amendment, while other courts neuter the action into non-existence.

Alienation, as a concept, has been through many twists and turns over time with respect to its definition and whether or not it should be considered a diagnostic "syndrome.

There has been a great deal of media attention the past several years about the JOBS Act. It has various components that do various things. The aspect of the JOBS Act that has the potential to touch the largest number of Americans is Title III (Crowdfunding).

State and federal courts have long faced the difficulty of adapting purchaser-focused product liability doctrines to the pharmaceutical and medical device areas, where physicians mediate the interaction between the manufacturer and the ultimate consumer, the patient.The learned intermediary doctrine addresses this dilemma by providing that manufacturers of prescription medicines need warn only physicians of the relevant risks associated with their products.